Sagility India IPO Subscribed over 3.20x on its last day of subscription

Sagility India IPO Subscribed over 3.20x on its last day of subscription wherein QIB subscribed 3.52x, NII subscribed 1.93x, and RII subscribed 4.16x.
Sagility India IPO

Table of Contents

Sagility India IPO subscriptionĀ started on Tuesday, November 5, and will close on November 7 as per the schedule. The price band is set at ₹28 to ₹30 per share with a face value of ₹10.

Sagility India IPO Subscription Status

Sagility India IPO Subscribed over 3.20x on its last day till 05.00 PM on 7th November.

  • Sagility India IPOĀ subscription QIB investors portion is 3.52x times, while NII subscribed 1.93x times and RII investors subscribed 4.16x times.
  • The company has received bids forĀ 1,23,99,74,500Ā shares againstĀ 38,70,64,594Ā shares on offer on the last day.
  • Sagility India IPO Subscribed over 0.23x on day 1.
  • Sagility India IPO Subscribed over 0.52x on day 2.

About Sagility India IPO

Sagility India Limited was formed on July 28, 2021, to provide tailored solutions for various medical sectors, such as hospitals, health systems, physician groups, labs, and DME companies. It has a revenue of 47,535.60 crore which has increased compared to the last two years. This company not only serves domestic clients but also expands its business overseas. They are strengthening their relationships with existing clients while also acquiring new ones and enhancing their technology for the betterment of customers.

Sagility India IPO Company Financial Report

The company reported revenue of ₹4,781.5 crores in 2024 against ₹4,236.06 crore in 2023. The company reported a profit of ₹228.27 crores in 2024 against a Profit of ₹143.57 crores in 2023.

Sagility India IPO GMP:

Sagility India IPO GMPĀ was ₹1 as of Thursday, November 7th. That indicates the IPO is trading at ₹31 with ₹1 premium in the grey market against the issue price of ₹30.

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.